1st Quarter - Report

SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.) for SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.)

Firm
Client
Income
—
Expenses
$390,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Discussions related to the IPAB Issues regarding general health care reform (no specific bill#) Essential Health Benefits Discussions regarding Perscription Drug User Fee Act (PDUFA) Reauthorization

LobbyistCovered position, as disclosed
ENGEL BURNS —
ANTHONY MAGNETTI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Issues regarding Medicare Part D, Medicare reimbursement issues Discussions regarding Medicare Part B

LobbyistCovered position, as disclosed
ENGEL BURNS —
ANTHONY MAGNETTI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.